MEF2C and acute lymphoblastic leukemia: Moreover, MEF2C was considered one of the driving oncogenes in acute lymphoblastic leukemia and demonstrated to be overexpressed in T cells from disease patients (Colomer‐Lahiguera et al., 2017).